Exploring the Treatment Duration of PD-1 Neoadjuvant Therapy in Stage II-III dMMR Rectal Cancer

Clinical trial NCT06613165 · RECRUITING

Trial details

NCT number: NCT06613165
Sponsor: Xijing Hospital
Status: RECRUITING
Study type: OBSERVATIONAL

Immune-related Adverse Event Neoadjuvant Therapy dMMR Colorectal Cancer

Start date: 2025-01-01
Primary completion: 2026-09-20
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.